|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.355 MYR | +2.90% |
|
-6.58% | +18.33% |
Sunzen Biotech Berhad reported earnings results for the fourth quarter ended December 31, 2022. For the fourth quarter, the company reported sales was MYR 17.04 million compared to MYR 29 million a year ago. Net income was MYR 1.14 million compared to MYR 0.667 million a year ago.
Basic earnings per share from continuing operations was MYR 0.0016 compared to MYR 0.0012 a year ago. Diluted earnings per share from continuing operations was MYR 0.0015 compared to MYR 0.0011 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +18.33% | 53.48M | |
| -2.47% | 280B | |
| -8.52% | 88.33B | |
| +0.68% | 40.46B | |
| -11.02% | 39.32B | |
| -1.53% | 37.81B | |
| +1.27% | 36.98B | |
| -17.00% | 29.42B | |
| -4.37% | 29.35B | |
| +5.24% | 23.44B |
SUNZEN BIOTECH 
